AI-controlled anesthesia during gastrointestinal endoscopy
Automated Anesthesia System-Gastrointestinal Endoscopy (AAS-GE): a Reinforcement Learning Based Control for Anesthesia During Gastrointestinal Endoscopy
This study tests whether an AI system can safely and effectively manage anesthesia during gastrointestinal endoscopy, compared to traditional anesthesia given by healthcare professionals, for adults aged 18-65.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 164 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd. Industry-sponsored |
| Locations | 5 sites (Anxi, Fujian and 4 other locations) |
| Trial ID | NCT06857344 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to compare the effectiveness of an AI-controlled anesthesia system against traditional anesthesia administered by clinical professionals during gastrointestinal endoscopy. Participants aged 18-65 with ASA scores I-II will be included, and the study will assess whether the AI model can safely and effectively manage anesthesia. The trial will involve fasting protocols and will evaluate success rates between the two groups to determine if AI can match or exceed the performance of human anesthetists.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-65 with ASA physical status class I-II who require gastrointestinal endoscopy.
Not a fit: Patients with significant medical history, such as cardiac or metabolic disorders, or those with obesity may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance the safety and efficiency of anesthesia management during gastrointestinal procedures.
How similar studies have performed: While the use of AI in anesthesia is an emerging field, similar studies have shown promising results, indicating potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * American Society of Anesthesiologists (ASA) physical status class I-II * Expected operation duration less than 1 hour Exclusion Criteria: * History of cardiac, hepatic, renal, or metabolic disorders (e.g., diabetes, hypertension, sleep apnea) * Known allergy to opioids or ciprofloxacin components * Cachexia * Hypothermia; history of narcotic abuse; chronic alcoholism; obesity (BMI \>30); patients with apnea * Current pregnancy or lactation * History of substance abuse or alcohol dependence * Participation in any other drug clinical trial within the past 3 months * Obesity (BMI \>30 kg/m²) * Procedure termination due to gastric retention or inadequate bowel preparation
Where this trial is running
Anxi, Fujian and 4 other locations
- Anxi County Hospital — Anxi, Fujian, China (Recruiting)
- Jinjiang Municipal Hospital, Shanghai Sixth People's Hospital Fujian Campus — Jinjiang, Fujian, China (Recruiting)
- Xinzheng Public People's Hospital — Xinzheng, Henan, China (Recruiting)
- Henan Provincial People's Hospital — Zhengzhou, Henan, China (Recruiting)
- Zhengzhou Central Hospital — Zhengzhou, Henan, China (Recruiting)
Study contacts
- Study coordinator: Dr. Chu
- Email: jimmynetchu@163.com
- Phone: +86 138 3810 0696
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.